The Consejo Profesional de Desarrollo Agropecuario (CPDA), an organisation best known for its work across Latin American agriculture, is expanding its presence in the United States as biopesticides and tightening pesticide regulation reshape how American growers protect their crops.

The move, reported by agribusiness publication AgroLatam, signals that the trade body sees the U.S. market as the next battleground for biological crop protection advocacy, standards work and industry coordination. It comes at a moment when the balance between conventional chemistry and biological alternatives is shifting in growers' spray programmes.

Why the U.S. now

The expansion is not a random bet. The United States has become one of the fastest-growing markets for biopesticides worldwide, driven by three forces that CPDA's Latin American members already know well.

First, regulation. Federal and state-level reviews continue to narrow the list of approved conventional actives, particularly organophosphates and older broad-spectrum products. Growers facing the loss of familiar chemistries need registered alternatives, and biopesticides — derived from microbes, botanical extracts and other natural sources — face a comparatively streamlined registration path under U.S. Environmental Protection Agency rules.

Second, residue limits. Export-oriented producers must meet maximum residue limits set by destination markets, and buyers increasingly demand lower chemical footprints. Biological products, which often carry zero-day pre-harvest intervals and favourable re-entry rules, give growers flexibility late in the season when conventional products cannot be used.

Third, resistance management. Repeated use of single-mode-of-action chemistry has produced resistant pest and disease populations in key U.S. crops. Biopesticides, with novel or multiple modes of action, slot into rotation programmes that preserve the efficacy of remaining conventional products.

What CPDA brings

CPDA's core business is professional development and technical coordination for the crop protection sector. In Latin America it has worked on good application practices, product stewardship and the regulatory dialogue between industry and governments — competencies that translate directly to the U.S. context, where state-level pesticide regulation adds complexity beyond federal rules.

An expanded U.S. footprint gives the organisation a seat at the table as American regulators, land-grant universities and grower groups debate how biologicals should be evaluated, labelled and integrated into integrated pest management programmes.

For farmers, the practical significance is indirect but real. Industry bodies that coordinate standards and training shorten the learning curve on new product categories. When biopesticide performance data, storage requirements and tank-mix compatibility are standardised and communicated well, growers waste less money on misapplied product.

The biopesticide backdrop

The category CPDA is betting on has moved from niche to mainstream in under a decade. Microbial products based on Bacillus, Trichoderma and beneficial fungi now sit alongside conventional chemistry in programmes for soybeans, corn, specialty crops and high-value horticulture across the Americas.

Adoption drivers differ by crop. In row crops, seed treatments and in-furrow biologicals have grown fastest, priced competitively enough to fit broad-acre budgets. In fruit and vegetable production, where residue scrutiny is sharpest, foliar biopesticides command premium positioning because they solve a specific harvest-window problem chemistry cannot.

The regulatory environment on both continents is pushing in the same direction. Latin American regulators have tightened restrictions on several older actives in recent years, a pattern that shaped CPDA's home market experience. U.S. reviewers have followed a similar trajectory. That parallel is part of what makes the expansion logical: the organisation is exporting expertise built under conditions the U.S. market is now entering.

What it means for field decisions

Growers should not expect immediate changes on farm. An industry-body expansion works on the timescale of standards, training programmes and regulatory engagement, not product launches.

But the medium-term effects are worth tracking. Stronger coordination around biologicals typically produces better trial data, clearer label guidance and more reliable supply chains — the three pain points growers most often cite when they trial biopesticides and find results inconsistent.

Watch next for CPDA's first concrete U.S. activities: partnerships with American grower associations, training programmes for applicators and advisors, and any position papers on biological product standards. Those announcements will show whether the expansion is a full operational build-out or an advocacy and networking beachhead. Timing and scope should become clear as the organisation rolls out its American programme in the coming months.